More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD ...

Fatty liver disease happens when too much fat builds up in the liver. Metabolic dysfunction-associated steatohepatitis (MASH) is a severe type of fatty liver disease where fat buildup causes liver ...

Liver cancer, primarily hepatocellular carcinoma, originates in the liver, with hepatitis B and C as major risk factors. Diagnosis involves physical exams, blood tests, imaging, and possibly biopsy to ...

Liver cancer is one of the three deadliest cancers worldwide, and metabolic dysfunction-related cases have become ...

Researchers have made a groundbreaking advancement in medical therapies by developing smart nanoparticles that effectively treat liver disease. This innovation represents a significant leap in ...

More than 30% of people worldwide have metabolic dysfunction–associated steatotic liver disease (MASLD; formerly nonalcoholic fatty liver disease), including 65% of those with type 2 diabetes (T2D) ...

A groundbreaking international trial has found that semaglutide, a drug best known for treating diabetes and obesity, can also reverse a dangerous liver disease called MASH in nearly two-thirds of ...

Allegheny Health Network's 'Alcohol Bridge Clinic' Transforms Treatment of Alcohol-Associated Liver Disease Multidisciplinary clinic shows early success in helping patients achieve sobriety and ...

People with compromised liver function may be able to reduce their risk of liver cancer or slow its progression with a simple dietary change: eating less protein. A Rutgers-led study in Science ...

Lucknow: Hepatic venous pressure gradient (HVPG), special medical test to gauge pressure inside liver, was performed for the ...

Your liver is one of the most patient organs in your body, quietly handling hundreds of essential functions while rarely complaining about the abuse you put it through. But this stoic nature works ...

ALL RIGHT, ERIC, THANKS SO MUCH. A GROWING LIVER PROBLEM IS NOW AFFECTING MILLIONS OF PEOPLE. KOAT UNM HEALTH EXPERT DOCTOR ASH SPOKE WITH DARLENE MELENDEZ ABOUT IT. NONALCOHOLIC FATTY LIVER DISEASE ...